MedTrace Logo

Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT03240315 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 442

Last updated 2026-01-12

No results posted yet for this study

Summary

This is a 3-year longitudinal study designed to establish a personalized prediction and prevention system for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Data will be prospectively collected from patients with chronic obstructive pulmonary disease (COPD) and healthy control participants, including clinical characteristics, pathophysiological parameters, etiological factors, and immunological information. These data will be analyzed using data mining approaches combined with Internet-based technologies.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • Guangzhou Science and Technology Innovation Commission,China

    collaborator UNKNOWN

  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • Rongchang Chen, MD/Ph.D · Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University,China

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2026-09-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03240315 on ClinicalTrials.gov